Allbirds Stock’s Next Test Is Days Away After Credit Reset and AI Pivot
Allbirds cut its revolving credit facility to $44.2 million and added two new term loans, according
Atomera Stock Faces Another Test Monday After 11% Drop Friday
Atomera Inc. shares fell 10.7% to $9.98 Friday, capping a volatile week that saw the stock surge 31.1% Tuesday and finish up 8% overall. No new company news was released. Atomera last
MillerKnoll Drops as Traders Eye June 24
MillerKnoll shares fell 1.8% to $16.18 Friday as the stock went ex-dividend, ahead of its June 24 earnings report. HNI, which owns Steelcase, also declined, weighing on office-furniture stocks. MillerKnoll’s next dividend of $0.1875 per share is payable July 15 to holders as of May 29. The company last reported Q3 sales of $926.6 million and adjusted EPS of $0.43.
AirSculpt Shares Slip as June Investor Test Looms
AirSculpt Technologies shares fell 2.9% to $5.38 Friday, trailing small-cap peers ahead of two June investor events where executives aim to defend the company’s outlook. First-quarter revenue was flat at $39.4 million, with net loss narrowing to $2.4 million. The company raised $14.6 million in a share sale this quarter, using most to pay down debt. Investors remain focused on management’s response to weight-loss drug competition.
vTv Therapeutics Drops as Diabetes Study Date Approaches
vTv Therapeutics shares fell 1.1% to $33.14 Friday afternoon, underperforming biotech indexes as investors await updates on its diabetes drug cadisegliatin. The company last reported on May 13, saying Phase 3 CATT1 enrollment remains on track for Q3 2026. Cash reserves rose to $98.1 million at March 31 after a $20 million licensing payment. No new filings or press releases have been issued since the quarterly report.
Aurinia Stock Dips as Traders Eye Lupkynis Data
Aurinia Pharmaceuticals shares fell 0.9% to $15.21 in late morning Nasdaq trading Friday, underperforming the broader biotech sector. Investors focused on Lupkynis sales and the upcoming June 3 shareholder meeting, with no new company news released. The company relies on Lupkynis as its only approved drug and faces competition from GSK’s Benlysta and Genentech’s Gazyva.
Eva Live Stock Falls As $20 Million AI Senior-Care Bet Runs Into Cash Questions
Eva Live shares fell 3.4% to $3.275 in early Nasdaq trading Friday after the company announced a preliminary deal to invest up to $20 million for a 25% stake in Spiro Senior Care. The company reported a first-quarter net loss of $8.6 million on $3.9 million revenue. Trading volume reached 43,221 shares, with a market value near $118 million. Wall Street indexes opened higher.
Prospect Capital books $328 million exit, gives PSEC stock a new driver
Prospect Capital shares rose 2.1% to $2.37 after announcing the sale of Valley Electric to MYR Group for about $328 million. Prospect expects net exit proceeds of $280 million, or 9.5% of its March 31 net asset value. The stock remains below NAV, reflecting investor concerns despite the sale. MYR plans to fund the purchase with cash and credit.
Synergy CHC Stock Moves After Big Volume Jump Ahead of Nasdaq Deadline
Synergy CHC shares fell 9% to $0.253 in premarket trading Friday after a 10.6% jump Thursday on heavy volume of 116.2 million shares. The move follows an SEC-effective S-1 registration for Hudson Global Ventures to sell up to 101.7 million shares. Synergy faces a Nasdaq bid-price warning and reported a first-quarter net loss of $2.57 million on revenue of $5.49 million.
GlobalFoundries shares to watch after Mubadala sells 22 million shares
GlobalFoundries shares fell 0.5% to $80.63 in after-hours trading Thursday after Mubadala sold 22 million shares, cutting its stake to 73%. Trading volume hit about 9.6 million, with the company’s market cap near $44.5 billion. The sale followed a 9.8% drop Wednesday after reports Mubadala aimed to raise $1.91 billion in a block trade. GlobalFoundries’ second-quarter revenue outlook topped Wall Street estimates.
Prospect Capital books $328 million exit, gives PSEC stock a new driver
Prospect Capital shares rose 2.1% to $2.37 after announcing the sale of Valley Electric to MYR Group for about $328 million. Prospect expects net exit proceeds of $280 million, or 9.5% of its March 31 net asset value. The stock remains below NAV, reflecting investor concerns despite the sale. MYR plans to fund the purchase with cash and credit.
Synergy CHC Stock Moves After Big Volume Jump Ahead of Nasdaq Deadline
Synergy CHC shares fell 9% to $0.253 in premarket trading Friday after a 10.6% jump Thursday on heavy volume of 116.2 million shares. The move follows an SEC-effective S-1 registration for Hudson Global Ventures to sell up to 101.7 million shares. Synergy faces a Nasdaq bid-price warning and reported a first-quarter net loss of $2.57 million on revenue of $5.49 million.
GlobalFoundries shares to watch after Mubadala sells 22 million shares
GlobalFoundries shares fell 0.5% to $80.63 in after-hours trading Thursday after Mubadala sold 22 million shares, cutting its stake to 73%. Trading volume hit about 9.6 million, with the company’s market cap near $44.5 billion. The sale followed a 9.8% drop Wednesday after reports Mubadala aimed to raise $1.91 billion in a block trade. GlobalFoundries’ second-quarter revenue outlook topped Wall Street estimates.
NI Holdings Trades Close to $14 After Board Filing
NI Holdings shares closed nearly unchanged at $14.02 Thursday after governance updates and an 8-K filing. The company reported first-quarter net income of $12.5 million, up from $6.5 million, as it continued to exit non-standard auto insurance. Home and farm premiums rose 8.3%. About 8,144 shares traded.
Newell Brands Stock Just Slid Again — Why the Sharpie Maker’s Turnaround Is Being Tested
Newell Brands shares fell about 4% Thursday afternoon to $3.515, underperforming broad U.S. market gains. The drop follows a brief rebound and comes ahead of Friday’s dividend record date. Investors remain cautious despite a raised 2026 outlook, citing weak sales, high debt, and unresolved tariff refunds. Trading volume stayed below average as the stock continued to lag sector peers.
Viking Therapeutics Stock Draws Wall Street Attention with Obesity Pill Competition Growing
Viking Therapeutics shares rose 1.7% to $32.19 after Lake Street initiated coverage with a Buy rating and an $89 price target, citing potential for its obesity drug VK2735. Phase 2 trial data showed up to 12.2% mean weight loss in 13 weeks. The company’s market cap stood at $3.72 billion. Board elections and auditor approval were disclosed in a May 26 SEC filing.
Vital Farms Shares Fall as Egg Glut Drags On, Nasdaq Sets New Highs
NEW YORK, May 30, 2026, 16:04 EDT Vital Farms Inc. shares slipped 4.2% to $10.01 at Friday’s close, wrapping up a shortened post-Memorial Day week in the red. The stock traded between $9.54 and $10.60 this week and ended about 1.2% down from May 22. (Investing.com) Markets kept moving higher this week. The S&P 500 notched its ninth weekly win in a row, and the Nasdaq Composite gained 2.4% for the week, both closing at new highs. But Vital Farms was left out. The stock is trading like investors see a company still working through its own issues. (AP News)
Motorcar Parts Shares Head for Key Test After Uneventful Rebound
Motorcar Parts of America shares fell 1.8% Friday to $11.06 but ended the week up 1.4%. The company reported fiscal Q3 net sales dropped to $167.7 million from $186.2 million a year earlier, citing a major customer’s order cuts. CEO Selwyn Joffe will speak at Oppenheimer’s virtual consumer conference on June 9. No earnings date is set for next week.
EGH Stock Drifts Near $10.35 as Hecate Deal Deadline Looms
EGH Acquisition Corp. closed Friday at $10.35, nearly unchanged for the week, as investors awaited further merger filings with Hecate Energy Group. The SPAC’s stock moved up just 0.2% since May 22, lagging the Nasdaq-100’s 2.9% gain. EGH and Hecate plan to complete their $1.2 billion merger by mid-2026, pending shareholder approval. EGH reported $1.03 million in net income last quarter, mainly from trust interest.
DT Cloud Star Holds Steady at $11.27; Market Still Watches PrimeGen Deal
DT Cloud Star Acquisition Corp. closed Friday at $11.27, barely changed in thin trading, with just 1,985 shares exchanged. No new SEC filings appeared, and the last major update remains the May 14 Schedule 13G. The company faces a Nasdaq compliance deadline after falling below the required 400 public holders. Its proposed $1.5 billion merger with PrimeGen US is still pending.
REalloys Falls Ahead of Weekend After Rare-Earth Deal Move
REalloys Inc. fell 5.9% Friday to $9.16, ending the week down 6.4% despite announcing new rare-earth supply deals. Investors showed little response to a non-binding MOU with Ramaco Resources for potential supply from Wyoming and a 15-year offtake agreement for Greenland rare-earth concentrate. Other rare earth stocks, including Ramaco and MP Materials, also declined. U.S. markets were closed Monday for Memorial Day.
GDS Stock Gains, but There’s a Catch to the AI Data Center Surge
GDS Holdings’ U.S. ADRs closed at $35.45 Friday, up 0.6%, but remain 12% below pre-earnings levels. Hong Kong shares jumped 4.6% to HK$33.28 but ended the week slightly down. Q1 net revenue rose 23.6% to RMB3.37 billion, with most profit from a DayOne Data Centers gain. Investors are watching record AI-related bookings but remain cautious about revenue timing.
Payoneer shares edge higher ahead of CEO comments
Payoneer Global Inc. closed at $5.20 Friday, up 1.96% for the day and 5.26% for the holiday-shortened week, though shares remain down 7.47% in 2026 and 23.87% over the past year. The company last reported first-quarter revenue of $261.6 million, with B2B payment volume up 44%. CEO John Caplan is scheduled to speak at a June 2 investor conference. Benchmark raised its price target to $9, maintaining a Buy rating.
CareCloud Gains for the Week After Deal News, Monday Trading Next
CareCloud shares closed at $2.35 Friday, up 1.29% after announcing its acquisition of Empower Healthcare & Compliance Partners. The company used operational cash flow for the deal, which closed May 22, and does not expect a major impact on 2026 earnings. First-quarter revenue rose 13% to $31.3 million, with a net loss of 1 cent per share for common shareholders. The S&P 500 and major indexes also gained for the week.
MediWound Shares Slide This Week; BARDA Moves in Focus
MediWound Ltd. shares fell 1.6% Friday to $14.33, down 13.6% since May 22, after first-quarter revenue dropped to $1.5 million from $4.0 million a year earlier. Net loss widened to $3.0 million. The company maintained its 2026 revenue forecast, expecting most sales later in the year. CEO Ofer Gonen cited slow enrollment in the EscharEx VALUE trial and anticipated second-half revenue from government contracts.
Manhattan Associates Stock Jumped Before the Weekend. A Quick Test Looms
Manhattan Associates (MANH) rose 4.8% Friday to $150.05, up 8.2% for the week. Barclays cut its price target to $201 but kept an Overweight rating. The company last reported Q1 revenue of $282.2 million and a backlog of $2.35 billion. Manhattan is pushing AI products but warns in filings of possible legal and compliance risks.
Sezzle Stock Tops Nasdaq This Week as Valuation Comes Into Focus
Sezzle Inc. closed Friday at $118.15, down 0.7% for the day but up 15% for the week, outpacing the Nasdaq’s 2.4% weekly gain. The company recently reported Q1 gross merchandise volume up 37.3% to $1.1 billion and net income up 41.9% to $51.3 million. No new company news drove Friday’s trading. Analyst price targets remain below the current share price.
Ouster Stock Just Ripped 24% in a Short Week. The $75 Wall Street Call Is Only Part of the Story
Ouster shares surged 8.79% Friday to $46.05, up 24.36% for the week, after Roth Capital initiated coverage with a $75 target and Buy rating. The company also announced a deal to supply digital lidar to Germany’s ARGUS Interception for counter-drone systems. Ouster reported Q1 revenue of $49 million, a 49% increase, but posted a $17 million net loss. U.S. markets were closed Monday for Memorial Day.
East West Bancorp Shares Slip in Holiday Week
East West Bancorp closed at $122.54 Friday, down 0.4% for the day and 0.5% for the holiday-shortened week, underperforming regional-bank peers. The bank reported record Q1 loans and deposits, but investors weighed interest-rate risks and rising deposit costs. The SPDR S&P Regional Banking ETF gained 0.3% for the week. U.S. markets were closed Monday for Memorial Day.
SU Group’s Brutal Week Leaves $1 Line in Focus Before Monday Trade
SU Group Holdings’ Nasdaq-listed shares fell 31.5% to $1.02 Friday, extending a weeklong slide from $3.44 despite recent contract wins and an operating update. The drop followed a $6 million public offering with warrants that raised dilution concerns. Fiscal 2025 results showed revenue up 5.6% but gross margin down to 16% and a net loss of HK$18.5 million.
First Community Bankshares Stock Ticks Up After Dividend Payout
First Community Bankshares shares closed at $43.11 Friday, up 0.49%, with volume at 112,038. The company paid a 31-cent quarterly dividend May 29 and reported Q1 net income of $12.03 million. Insider filings showed routine stock grants and conversions by executives. Assets rose to $3.64 billion after the Hometown Bancshares acquisition in January.
Allbirds Stock’s Next Test Is Days Away After Credit Reset and AI Pivot
Allbirds cut its revolving credit facility to $44.2 million and added two new term loans, according to a May 28 SEC filing. Shares closed Friday at $4.12, down 3.5% on the day. A shareholder vote on June 3 will decide the sale of its footwear assets and approval for a large share issuance. The company has begun buying Nvidia GPU equipment as it shifts toward AI infrastructure.
Atomera Stock Faces Another Test Monday After 11% Drop Friday
Atomera Inc. shares fell 10.7% to $9.98 Friday, capping a volatile week that saw the stock surge 31.1% Tuesday and finish up 8% overall. No new company news was released. Atomera last reported a Q1 net loss of $6.1 million on $11,000 revenue and raised cash through share sales. The PHLX Semiconductor Index rose 5.1% for the week, but Atomera’s swings were far larger.
BitFuFu Slides as Bitcoin Struggles—Traders Look to Next Week
BitFuFu shares fell 7% Friday to $1.86 after the Singapore-based Bitcoin miner reported a wider first-quarter net loss of $35 million and a 6.8% revenue drop to $72.7 million. Self-mining revenue fell sharply, while cloud mining revenue rose 7.1% to $57.5 million. The company ended the quarter with $141.5 million in cash and digital assets, including 1,794 Bitcoin. U.S. crypto mining peers traded mixed.
IPG Photonics Shares End Week Lower With Next Week in Focus
IPG Photonics shares fell 2.4% to $114.52 on Friday, ending the week down 3.8% despite broader market gains. The company expects Q2 revenue between $260 million and $290 million, with adjusted EPS of 25 to 55 cents and EBITDA of $32 million to $48 million. Tariffs are expected to cut gross margin by about 1.5 points. IPG settled a patent dispute with Trumpf for $13.5 million.
Methanex Shares Dip With Focus Shifting to June Methanol Pricing
Methanex shares fell 1.22% to $59.10 on Nasdaq and 1.14% to C$81.56 in Toronto on Friday, underperforming major indexes. June methanol contract prices were set at $4.45 a gallon in North America, $740 a tonne in Asia Pacific, and $610 in China. Trading volume lagged the previous week. Investors await signs that higher methanol prices will boost cash flow.